Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ehl

Showing results (191-200 of 239) with videos related to

Pageof 24
Sort By:
The Lancet. Rheumatology|March 2, 2025
Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based studyJerome Hadjadj, Anna Wolfers, Oleg Borisov, et al.
Blood|February 14, 2013
The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2Birthe Jessen, Sebastian F N Bode, Sandra Ammann, et al.
Arthritis and Rheumatism|January 1, 2008
The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation studyNicolino Ruperto, Angelo Ravelli, Angela Pistorio, et al.
The Journal of Allergy and Clinical Immunology|October 4, 2023
Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndromeOlivier Pellé, Solange Moreno, Myriam Ricarda Lorenz, et al.
The Journal of Allergy and Clinical Immunology|December 26, 2025
Somatic STAT5B<sup>N642H</sup> mutations shape variable immune landscapes resulting in heterogenous immune diseasesSarah Grün, Anne Rensing-Ehl, Tobias Suske, et al.
Journal of Clinical Immunology|February 27, 2023
Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)Carsten Speckmann, Uta Nennstiel, Manfred Hönig, et al.
Clinical Immunology (Orlando, Fla.)|September 23, 2023
C-terminal variants in CDC42 drive type I interferon-dependent autoinflammation in NOCARH syndrome reversible by ruxolitinibFriedrich G Kapp, Stefanie Kretschmer, Cora C A Beckmann, et al.
Journal of Clinical Immunology|March 14, 2026
Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening ProgramLea Graafen, Carsten Speckmann, Shahrzad Bakhtiar, et al.
Blood|July 3, 2024
Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosisSamuel C C Chiang, Laura E Covill, Bianca Tesi, et al.
Blood|November 22, 2023
Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputationSvea Böhm, Katharina Wustrau, Jana Pachlopnik Schmid, et al.
Pageof 24

Showing results (191-200 of 239) with videos related to

Sort By:
Pageof 24
The Lancet. Rheumatology|March 2, 2025
Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based studyJerome Hadjadj, Anna Wolfers, Oleg Borisov, et al.
Blood|February 14, 2013
The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2Birthe Jessen, Sebastian F N Bode, Sandra Ammann, et al.
Arthritis and Rheumatism|January 1, 2008
The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation studyNicolino Ruperto, Angelo Ravelli, Angela Pistorio, et al.
The Journal of Allergy and Clinical Immunology|October 4, 2023
Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndromeOlivier Pellé, Solange Moreno, Myriam Ricarda Lorenz, et al.
The Journal of Allergy and Clinical Immunology|December 26, 2025
Somatic STAT5B<sup>N642H</sup> mutations shape variable immune landscapes resulting in heterogenous immune diseasesSarah Grün, Anne Rensing-Ehl, Tobias Suske, et al.
Journal of Clinical Immunology|February 27, 2023
Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)Carsten Speckmann, Uta Nennstiel, Manfred Hönig, et al.
Clinical Immunology (Orlando, Fla.)|September 23, 2023
C-terminal variants in CDC42 drive type I interferon-dependent autoinflammation in NOCARH syndrome reversible by ruxolitinibFriedrich G Kapp, Stefanie Kretschmer, Cora C A Beckmann, et al.
Journal of Clinical Immunology|March 14, 2026
Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening ProgramLea Graafen, Carsten Speckmann, Shahrzad Bakhtiar, et al.
Blood|July 3, 2024
Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosisSamuel C C Chiang, Laura E Covill, Bianca Tesi, et al.
Blood|November 22, 2023
Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputationSvea Böhm, Katharina Wustrau, Jana Pachlopnik Schmid, et al.
Pageof 24